Correlation Between Tff Pharmaceuticals and Oncorus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Oncorus, you can compare the effects of market volatilities on Tff Pharmaceuticals and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Oncorus.

Diversification Opportunities for Tff Pharmaceuticals and Oncorus

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tff and Oncorus is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Oncorus go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Oncorus

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to generate 0.28 times more return on investment than Oncorus. However, Tff Pharmaceuticals is 3.62 times less risky than Oncorus. It trades about -0.07 of its potential returns per unit of risk. Oncorus is currently generating about -0.15 per unit of risk. If you would invest  1,198  in Tff Pharmaceuticals on August 31, 2024 and sell it today you would lose (1,164) from holding Tff Pharmaceuticals or give up 97.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy2.94%
ValuesDaily Returns

Tff Pharmaceuticals  vs.  Oncorus

 Performance 
       Timeline  
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Tff Pharmaceuticals and Oncorus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tff Pharmaceuticals and Oncorus

The main advantage of trading using opposite Tff Pharmaceuticals and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.
The idea behind Tff Pharmaceuticals and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges